These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2842008)

  • 1. Hypothalamo-neurohypophyseal neuropeptides and experimental drug addiction.
    Kovács GL; Telegdy G
    Brain Res Bull; 1988 Jun; 20(6):893-5. PubMed ID: 2842008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists.
    Kovács GL; Sarnyai Z; Izbéki F; Szabó G; Telegdy G; Barth T; Jost K; Brtnik F
    J Pharmacol Exp Ther; 1987 May; 241(2):569-74. PubMed ID: 3033220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin and addiction: a review.
    Kovács GL; Sarnyai Z; Szabó G
    Psychoneuroendocrinology; 1998 Nov; 23(8):945-62. PubMed ID: 9924746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microinjection of oxytocin into limbic-mesolimbic brain structures disrupts heroin self-administration behavior: a receptor-mediated event?
    Ibragimov R; Kovács GL; Szabó G; Telegdy G
    Life Sci; 1987 Sep; 41(10):1265-71. PubMed ID: 3041139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous oxytocin inhibits morphine tolerance through limbic forebrain oxytocin receptors.
    Sarnyai Z; Viski S; Kriván M; Szabó G; Kovács GL; Telegdy G
    Brain Res; 1988 Nov; 463(2):284-8. PubMed ID: 2848611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute morphine treatment and morphine tolerance/dependence alter immunoreactive oxytocin levels in the mouse hippocampus.
    Kovács GL; Vecsernyès M; Laczi F; Faludi M; Telegdy G; Lászlò FA
    Brain Res; 1985 Feb; 328(1):158-60. PubMed ID: 4038622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats.
    Kovács GL; Borthaiser Z; Telegdy G
    Life Sci; 1985 Jul; 37(1):17-26. PubMed ID: 4040199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of neuropeptide FF (FMRF amide-like peptide) in the hypothalamo-neurohypophyseal system of Wistar and Brattleboro rats by light and electron microscopy.
    Boersma CJ; Sonnemans MA; Van Leeuwen FW
    J Comp Neurol; 1993 Oct; 336(4):555-70. PubMed ID: 8245225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats.
    Kovács CL; Van Ree JM
    Life Sci; 1985 Nov; 37(20):1895-900. PubMed ID: 4058258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxytocin in alcohol and drug abuse.
    King CE; Gano A; Becker HC
    Brain Res; 2020 Jun; 1736():146761. PubMed ID: 32142721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic osmotic stimuli increase salusin-beta-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-beta on [Ca2+]i increase and neurohypophyseal hormone release from the axon terminals.
    Saito T; Dayanithi G; Saito J; Onaka T; Urabe T; Watanabe TX; Hashimoto H; Yokoyama T; Fujihara H; Yokota A; Nishizawa S; Hirata Y; Ueta Y
    J Neuroendocrinol; 2008 Feb; 20(2):207-19. PubMed ID: 18047553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohypophyseal hormones in tolerance and physical dependence.
    Ritzmann RF; Colbern DL; Zimmermann EG; Krivoy W
    Pharmacol Ther; 1983; 23(2):281-312. PubMed ID: 6366829
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/withdrawal are mediated by the limbic system.
    Kovács GL; Izbéki F; Horváth Z; Telegdy G
    Behav Brain Res; 1984 Oct; 14(1):1-8. PubMed ID: 6542796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system effects of the neurohypophyseal hormones and related peptides.
    de Wied D; Diamant M; Fodor M
    Front Neuroendocrinol; 1993 Oct; 14(4):251-302. PubMed ID: 8258377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.
    Zhou Y; Proudnikov D; Yuferov V; Kreek MJ
    Brain Res; 2010 Feb; 1314():235-52. PubMed ID: 19914222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of hypothalamic pituitary adrenal axis on the effects of nifedipine in the development of morphine tolerance in rats.
    Esmaeili Mahani S; Motamedi F; Javan M; Ahmadiani A
    Pharmacol Biochem Behav; 2005 May; 81(1):152-7. PubMed ID: 15894073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin for the treatment of drug and alcohol use disorders.
    Lee MR; Weerts EM
    Behav Pharmacol; 2016 Dec; 27(8):640-648. PubMed ID: 27603752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative autoradiographic mapping of neurohypophysial hormone binding sites in the rat forebrain and pituitary gland--I. Characterization of different types of binding sites and their distribution in the Long-Evans strain.
    Freund-Mercier MJ; Stoeckel ME; Dietl MM; Palacios JM; Richard P
    Neuroscience; 1988 Jul; 26(1):261-72. PubMed ID: 2843790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.